JPH0472807B2 - - Google Patents

Info

Publication number
JPH0472807B2
JPH0472807B2 JP58078300A JP7830083A JPH0472807B2 JP H0472807 B2 JPH0472807 B2 JP H0472807B2 JP 58078300 A JP58078300 A JP 58078300A JP 7830083 A JP7830083 A JP 7830083A JP H0472807 B2 JPH0472807 B2 JP H0472807B2
Authority
JP
Japan
Prior art keywords
medium
molecular weight
cultured
human
malignant tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58078300A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59204122A (ja
Inventor
Tomoyuki Tajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koken Co Ltd
Original Assignee
Koken Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koken Co Ltd filed Critical Koken Co Ltd
Priority to JP58078300A priority Critical patent/JPS59204122A/ja
Priority to US06/583,011 priority patent/US4595657A/en
Priority to EP84303035A priority patent/EP0125125A3/en
Publication of JPS59204122A publication Critical patent/JPS59204122A/ja
Publication of JPH0472807B2 publication Critical patent/JPH0472807B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP58078300A 1983-05-06 1983-05-06 人の悪性腫瘍細胞増殖抑制剤の製造方法 Granted JPS59204122A (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP58078300A JPS59204122A (ja) 1983-05-06 1983-05-06 人の悪性腫瘍細胞増殖抑制剤の製造方法
US06/583,011 US4595657A (en) 1983-05-06 1984-02-23 Process for preparing an inhibiting agent against proliferation of animals malignant tumor cells
EP84303035A EP0125125A3 (en) 1983-05-06 1984-05-04 An agent for inhibiting the proliferation of malignant tumour cells and a process for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58078300A JPS59204122A (ja) 1983-05-06 1983-05-06 人の悪性腫瘍細胞増殖抑制剤の製造方法

Publications (2)

Publication Number Publication Date
JPS59204122A JPS59204122A (ja) 1984-11-19
JPH0472807B2 true JPH0472807B2 (https=) 1992-11-19

Family

ID=13658070

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58078300A Granted JPS59204122A (ja) 1983-05-06 1983-05-06 人の悪性腫瘍細胞増殖抑制剤の製造方法

Country Status (3)

Country Link
US (1) US4595657A (https=)
EP (1) EP0125125A3 (https=)
JP (1) JPS59204122A (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5933223A (ja) * 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤
JPS59162889A (ja) * 1983-03-07 1984-09-13 Koken Kk 人の悪性腫瘍細胞の増殖抑制剤の製造方法
JPS6028930A (ja) * 1983-07-28 1985-02-14 Koken Kk 人の癌由来細胞の増殖抑制剤の精製方法
JPS6028931A (ja) * 1983-07-28 1985-02-14 Koken Kk ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の濃縮方法
JP2004155670A (ja) * 2002-11-01 2004-06-03 Youichirou Naganushi 細胞賦活剤、細胞賦活剤製造方法及びその装置
RU2283654C1 (ru) * 2005-03-30 2006-09-20 Борис Владимирович Афанасьев Способ получения ростовых факторов белковой природы, ростовой фактор белковой природы и ингибитор пролиферации фибробластов
CA3078175C (en) * 2017-10-05 2023-06-20 Medical Corporation Ichikawa Clinic Method for preparing cell extract component or composition having cytocidal activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415553A (en) * 1973-08-06 1983-11-15 Dso "Pharmachim" Compositions, processes for their preparation and method for treatment of neoplasms
FR2302747B1 (fr) * 1975-03-03 1978-09-22 Inst Nat Sante Rech Med Procede d'obtention, a partir de macrophages de mammiferes, d'un produit therapeutique actif, notamment, a l'egard des cellules tumorales humaines et produit therapeutique ainsi obtenu
JPS58138383A (ja) * 1982-02-13 1983-08-17 Nippon Shinyaku Co Ltd 生理活性物質の製法
JPS5933223A (ja) * 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤
JPS59162889A (ja) * 1983-03-07 1984-09-13 Koken Kk 人の悪性腫瘍細胞の増殖抑制剤の製造方法

Also Published As

Publication number Publication date
US4595657A (en) 1986-06-17
JPS59204122A (ja) 1984-11-19
EP0125125A2 (en) 1984-11-14
EP0125125A3 (en) 1986-10-08

Similar Documents

Publication Publication Date Title
EP1349919B1 (fr) Cellules du tissu adipeux extramedullaire et leurs applications dans la reconstitution du tissu cardiaque
CN110499287A (zh) 简易制备胎盘间充质干细胞外泌体的方法
CN102686723A (zh) 用于治疗处理肿瘤疾病的成体干细胞衍生的条件培养基和/或成体干细胞
CH664974A5 (fr) Production du facteur de lyse des cellules-cibles.
EP0102801B1 (en) An agent for inhibiting proliferation of malignant tumour cells
EP3845635A1 (en) Method for producing fibroblast, and g-csf-positive fibroblast mass
JPH0472807B2 (https=)
CN115991737B (zh) 活性肽在制备促进脐带造血干细胞增殖的药物或培养基中的应用
JPS59162889A (ja) 人の悪性腫瘍細胞の増殖抑制剤の製造方法
JP2023091619A (ja) 腫瘍を縮小、又は消失させるための組成物
JPS6043386A (ja) ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の製造方法
EP0133029B1 (en) A process for producing inhibiting agents against proliferation of malignant tumour cells, and agents produced thereby
JPH10509028A (ja) 細胞成長調節因子
CN106893697A (zh) 一种携带抗肿瘤蛋白靶向性exosome的制备方法及其应用
JP2691557B2 (ja) 人の悪性腫瘍細胞増殖抑制剤
JPS601877B2 (ja) 高分子多糖類物質ｍｐｓ−８０及びその製造法
CN116790493A (zh) 一种经血源干细胞外泌体递送体系及其制备方法和应用
EP4713434A1 (en) Extracellular vesicles
IT8348851A1 (it) Procedimento per preparare una sostanza avente attivita' carcinostatica ed immunostimolante
CN118272446A (zh) Fgf21修饰的间充质干细胞外泌体制备、纯化浓缩的方法
Kelly et al. Quantitative and qualitative deficiency of T-lymphocyte colony formation in T-cell lymphoma-leukaemia
JPS5815921A (ja) 抗リンホトキシン感受性疾患剤
FR2488137A1 (fr) Composition pour favoriser la croissance des bifidobacteries, procede pour la fabricationde celle-ci et composition pharmaceutique la contenant
Bagnara et al. Megakaryocytopoiesis in bone marrow-derived stromal-hemopoietic cells co-cultures: action of Tamm-Horsfall glycoprotein
Fritsch et al. Biochemical and Biological Characterization of Tumor-Associated Lymphokine-Like Factors